Navin Fluorine International (532504) Q3 24/25 earnings summary

Executive summary

• Achieved strong revenue and profit growth in Q3 and 9M FY25, with resilience amid global uncertainties and robust performance across all business segments.

• Significant margin expansion and operational efficiency improvements observed year-over-year.

• Successful commissioning of the agro-specialty plant at Dahej (INR 540 crore investment); commercial dispatches started.

• Dewas site awarded EcoVadis gold medal for sustainability practices, placing among top 5% globally.

• Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were approved and reviewed by the Board and Audit Committee.

Financial highlights

• Q3 FY25 consolidated revenue: INR 606.2 crore, up 21% YoY and 17% QoQ; operating EBITDA: INR 147.3 crore, up 95% YoY and 37% QoQ.

• Q3 FY25 operating EBITDA margin: 24.3% (vs. 15.1% YoY, 20.7% QoQ); operating PBT: INR 98 crore, up 195% YoY and 49% QoQ.

• Q3 FY25 profit after tax: INR 84 crore; 9M FY25 revenue: INR 1,648 crore, up 13% YoY; 9M FY25 EBITDA: INR 355 crore, up 23% YoY.

• Q3 FY25 consolidated net profit: INR 83.60 crore; standalone net profit: INR 65.24 crore.

• Exceptional gain of INR 52.13 crore in Q3 & 9M FY24 from sale of surplus land; not repeated in FY25.

Outlook and guidance

• Strong order visibility for Q4 FY25 and into FY26 across specialty chemicals and CDMO; new molecules to be introduced in Q4 FY25 and Q1 FY26.

• Multiple capacity expansions on track, including R32 and AHF plants, expected to commission by FY25/FY26.

• CDMO segment targets $100 million revenue by FY27, with 30% from a major European contract.

• No upgrade to margin guidance; aim to exit FY25 at or near 25% EBITDA margin, focusing on sustainability.

• R32 market outlook remains constructive, with expected pricing upside in 2025.